The port site recurrence after a thoracoscopic and video-assisted esophagectomy for advanced XXXX .

@entity1 @entity1143 @entity902 @entity5 @entity957 @entity418 @entity420 @entity1487
INTRODUCTION: Thoracoscopic or video-assisted thoracic esophagectomies have been performed for the last 10 years. Nevertheless, some reports have showed a risk of dissemination with endoscopic or video-assisted surgery for @entity5 . This institute experienced three cases of port site recurrence after a thoracoscopic esophagectomy for advanced @entity418 . Following those cases, induction chemo-radiation therapy was performed for @entity1 with advanced @entity418 before thoracoscopic or video-assisted esophagectomy. Since introducing induction chemo-radiation therapy, no @entity1 have experienced port site recurrence after a thoracoscopic or video-assisted esophagectomy for advanced @entity418 . In this study, the two @entity1 groups are compared before and after the introduction of induction chemo-radiation therapy. @entity1 AND METHODS: Between November 1995 and December 2005, thoracoscopic and video-assisted esophagectomies were performed on 112 (72.7%) @entity1 out of 154 who underwent a surgical resection for @entity418 . The histologic type of @entity5 was @entity957 in 109 (97.4%) @entity1 and @entity420 in 3 (2.6%). Ninety-one @entity1 were @entity1 and 21 were @entity1 . The @entity5 was located in the upper thoracic esophagus in 22 (19.6%) @entity1 , the middle thoracic esophagus in 49 (43.8%), the lower thoracic esophagus in 34 (30.4%), and the abdominal esophagus in 7 (6.2%). RESULTS: Before December 1999, port site recurrence occurred in three cases of those of 29 @entity1 with clinical T2-T4 @entity418 from 3 to 6 months after surgery, and @entity1143 was observed in two of those @entity1 . Since January 2000, induction chemo-radiation therapy (low-dose @entity1487 and @entity902 + 40 Gy radiation) has been performed to 31 @entity1 with clinical T2-T4 disease, and port site recurrence has not occurred in any @entity1 who received trimodality therapy. CONCLUSIONS: We think that the trend toward less port site recurrences with induction therapy should be examined in future studies of video-assisted thoracic surgery esophagectomy to confirm our findings.
